Twelve weeks treatment with the DPP-4 inhibitor, sitagliptin, prevents degradation of peptide YY and improves glucose- and non-glucose-induced insulin secretion in patients with type 2 diabetes mellitus

Kasper Aaboe, Filip Krag Knop, Tina Vilsbøll, Carolyn F. Deacon, Jens Juul Holst, Sten Madsbad, Thure Krarup

93 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Twelve weeks treatment with the DPP-4 inhibitor, sitagliptin, prevents degradation of peptide YY and improves glucose- and non-glucose-induced insulin secretion in patients with type 2 diabetes mellitus'. Together they form a unique fingerprint.

Medicine & Life Sciences